Poloxamer Market 2019 by Business Opportunity, Innovations, Applications, Upcoming-Trends, Growth-Analysis, Demand-Insight, Segmentation, Top-Manufacturers and Forecast 2026

Market Size - USD 38,735.0 million in 2018, Market Growth - CAGR of 6.4%, Market Trends - Increasing adoption in the pharmaceutical industry.

According to the current analysis of Reports and Data, the global poloxamer market is expected to reach USD 38,735.0 million by year 2026, in terms of value at a CAGR of 6.4%. The varying length of polymer blocks gives rise to different polymers identified as 124, 188, 237, 338 and 407 among others showing a slight difference in their properties.

Get a Free Sample PDF Report to understand our report before you purchase: https://www.reportsanddata.com/sample-enquiry-form/1696

In market segmentation by manufacturers, the report covers the following companies-

BASF, Anshul Life Sciences, DeWolf Chemicals, Solvay, Sirion Biotech Gmbh, BioPharm International, Sigma-Aldrich, Planet Science, SpecialChem. BASF is a key player in the poloxamer market. With a global presence in North America, Europe, Asia Pacific, and South America, Africa & Middle East, the company offers poloxamers by the name - Kolliphor and Kollisolv. As of 2018, the company's total revenue accounted for USD 73.9 billion.

For the purpose of this report, Reports and Data has segmented the global poloxamer market on the basis of type, technology type, end use, and region:

Grade (Volume, Kilo Tons; 2019-2026 and Revenue, USD Million; 2019-2026)
Poloxamer 68
Poloxamer 88
Poloxamer 98
Poloxamer 108
Poloxamer 124
Poloxamer 188
Poloxamer 237
Poloxamer 338
Poloxamer 407

Method (Volume, Kilo Tons; 2019-2026 and Revenue, USD Million; 2019-2026)
Direct Solubilization
Thin Film methods
Temperature-induced emulsification

Application (Volume, Kilo Tons; 2019-2026 and Revenue, USD Million; 2019-2026)
Biotechnological Activity
Brain Injury Treatment
DNA Delivery
Microbiological Activity
Cardiovascular Treatment
Others

End-Use (Volume, Kilo Tons; 2019-2026 and Revenue, USD Million; 2019-2026)
Pharmaceutical Industry
Biotechnological Companies
Research Centers
Others

Regional Outlook (Volume, Kilo Tons; 2019-2026 and Revenue, USD Million; 2019-2026)
North America
Canada
Europe
Asia Pacific
Middle East & Africa
Latin America

Grab Your Report at an Impressive Discount! Please Click Here @ https://www.reportsanddata.com/discount-enquiry-form/1696

The size and structure of poloxamers assemblies, and their adsorption properties have made them useful in many applications, including: drug delivery, nanoparticle synthesis, cosmetics and emulsion formulation, effective dispersants for inks/pigments and as versatile anti-bio fouling coatings, to name a few.

Poloxamers can be used to increase the water solubility of hydrophobic, oily substances or otherwise increase the miscibility of two substances with different hydrophobicities. Owing to this property, poloxamers are commonly used in industrial applications, cosmetics, and pharmaceuticals. They have also been evaluated for various drug delivery applications and were shown to sensitize drug-resistant cancers to chemotherapy. In bioprocess applications, poloxamers are used in cell culture media for their cell cushioning effects because their addition leads to less stressful shear conditions for cells in reactors.

With respect to region, the Asia Pacific market is projected to be the chief revenue generating market during the forecast period. This market is also anticipated to grow at the highest CAGR of 7.6% during the forecast years. Increasing microbiological activities in the biotechnological and research centers in the region is a key factor influencing market growth.

Further key findings from the report suggest

The emulsification method that utilizes poloxamers allows for lower processing temperatures. The drug and solubilizing agent form an oily phase, which is encapsulated by the poloxamer. Multi-layer particles can be easily manufactured with this method. For instance, by first creating a mixture of drug with Tween 80 (poly (ethylene oxide) sorbitan monooleate) and soybean oil, more abundant, lipidlike aggregates can be formed and then these encapsulated by poloxamer.

The grade 338 segment is expected to grow at a CAGR of 5.1% till 2026. The significant share is due to the use of this grade of the compound as surfactants in pharmaceuticals and personal care products. However, a CIR (Cosmetic Ingredient Review) Expert Panel evaluated and concluded that 338 grade, when consumed at 5.0 g/kg/day, produced slight transient diarrhea whereas it produced no adverse effects at 0.2 or 1.0 g/kg/day.

Find the extensive Report Description, TOC and Table of Figure @ https://www.reportsanddata.com/report-detail/poloxamer-market

In conclusion, the Poloxamer Market report is a reliable source for accessing the Market data that will exponentially accelerate your business. The report provides the principal locale, economic scenarios with the item value, benefit, supply, limit, generation, request, Market development rate, and figure and so on. Besides, the report presents a new task SWOT analysis, speculation attainability investigation, and venture return investigation.

Contact Us:
Reports And Data
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.